CU Anschutz is the largest academic health center in the Rocky Mountain region. This is where dreams live!
The CU Anschutz Medical Campus fosters collaboration among students, researchers and clinicians. Campus architecture and state-of-the-art technology bridge education and research with two world-class hospitals: University of Colorado Hospital and Children’s Hospital Colorado. CU Anschutz is also a catalyst of regional economic development. Its economic impact on the state amounts to more than $2 b
08/14/2026
As everyone begins to arrive at our four campuses, we want to welcome all students to the University of Colorado. We’re so proud of everything that you’ll accomplish during your time at CU.
– President Todd Saliman, Chancellor Justin Schwartz, Chancellor Jennifer Sobanet, Chancellor Kenneth T. Christensen and Chancellor Donald Elliman
University of Colorado Boulder | UCCS | University of Colorado Denver | University of Colorado Anschutz
Caring for someone living with dementia can come with a lot of questions. Hillary Lum, MD, PhD, a CU Anschutz expert in geriatric medicine, shares three recommendations every dementia caregiver should know. 💛
Caregivers don’t have to navigate dementia care alone. The GUIDE Program at provides eligible people living with dementia and their caregivers with coordinated care, education, resources and ongoing support to help improve quality of life and reduce caregiver strain.
Learn more about the GUIDE Program and available caregiver resources: https://bit.ly/4qhEwiI.
08/12/2026
August at is all in the details. ⛅📸
08/11/2026
Researchers at examined data from more than 7,000 pediatric flu hospitalizations across eight influenza seasons, finding that children treated early with the antiviral oseltamivir were less likely to be admitted to the ICU and had shorter hospital stays.
The findings provide some of the strongest real-world evidence to date supporting antiviral treatment for hospitalized children with influenza and reinforce national recommendations to begin treatment as soon as possible.
🔗 Learn More: https://bit.ly/4qdzDrh.
08/08/2026
Years of research, including some of the earliest clinical trials at , have led to a breakthrough in the treatment of advanced bladder cancer.
A new phase 3 study published in The New England Journal of Medicine found that a novel combination therapy improved outcomes for patients with advanced muscle-invasive bladder cancer preparing for surgery. The study followed more than 800 patients at sites worldwide over nearly three years. Nearly 80% of patients who received the combination therapy were alive without their cancer returning two years later, compared with 66% of those who received standard chemotherapy.
CU Anschutz Vice Chancellor for Research Dr. Thomas Flaig, a co-author of the paper, was part of the team that advanced the therapy from its earliest clinical trials to this landmark study that could usher in a new era of care for bladder cancer patients.
🔗 Read More: https://bit.ly/4i2iSgi
08/04/2026
For more than 30 years, Jean Kutner, MD, MSPH, distinguished professor of medicine at University of Colorado Anschutz School of Medicine has helped shape the field of palliative care. Now, she is leading the ASCENT Consortium, a nationwide effort to strengthen the evidence behind care for people living with serious illness.
Supported by a $64 million NIH grant awarded last year, the consortium is investing in research, mentorship and collaboration to help ensure patients and families receive the care that matters most. 💫 Read more: https://bit.ly/3UcO3eZ.
GLP-1 medications have changed the way we think about obesity and weight loss. But these drugs don’t solely affect metabolism and body weight - they also impact the brain. 🧠
researcher Joseph Schacht, PhD, is investigating if GLP-1s can transform the way we treat alcohol use disorder. His clinical trial showed semaglutide medications, like Ozempic and Wegovy, resulted in reduced alcohol consumption and cravings in heavy drinkers, offering hope that new alcohol addiction treatments could be on the horizon.
Learn More: https://bit.ly/4fs4ZGP.
08/01/2026
Happy Colorado Day! 🏔️ Today we celebrate Colorado's admission as the 38th state and 150 years of the people, places and ideas that continue to shape it.
At , we're honored to be part of Colorado's story. Every day, our researchers, clinicians, educators and students are working to turn discoveries into better care for patients here at home and around the world. Colorado has always been a place where big ideas take shape. Here’s to 150 years!
07/31/2026
More than 650 physicians affiliated with University of Colorado Anschutz School of Medicine were recognized in the 2026 5280 Magazine Top Doctors list, representing nearly half of all physicians honored this year. 🖤💛
This recognition reflects ’s role as the Rocky Mountain region’s only academic medical campus and a global leader in health sciences research. Across more than 70 medical and surgical specialties at UCHealth University of Colorado Hospital and Children’s Hospital Colorado, our faculty physicians were recognized for the expertise they bring to patient care and discovery every day.
👉 Read more: https://bit.ly/4hHDFWk
07/29/2026
Could GLP-1 medications help transform treatment for alcohol addiction?
Alcohol use disorder affects millions, yet there haven’t been any new medications approved to treat it in 20 years. Now, new research suggests oral semaglutide — a medication commonly used for diabetes and weight loss — showed consistent reductions in harmful drinking behavior and cravings among heavy drinkers, offering hope for people who don’t respond to existing treatments.
🔗 Learn More: https://bit.ly/3RlkmYt